{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bioinformatics", "cancer", "natural products", "phytochemicals", "synthetic derivatives", "virtual drug screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35409325", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "13"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "02"}], "Language": ["eng"], "ELocationID": ["3966", "10.3390/ijms23073966"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "02"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-\u03baB Inhibitors.", "Abstract": {"AbstractText": ["The improvement of cancer chemotherapy remains a major challenge, and thus new drugs are urgently required to develop new treatment regimes. Curcumin, a polyphenolic antioxidant derived from the rhizome of turmeric (Curcuma longa L.), has undergone extensive preclinical investigations and, thereby, displayed remarkable efficacy in vitro and in vivo against cancer and other disorders. However, pharmacological limitations of curcumin stimulated the synthesis of numerous novel curcumin analogs, which need to be evaluated for their therapeutic potential. In the present study, we calculated the binding affinities of 50 curcumin derivatives to known cancer-related target proteins of curcumin, i.e., epidermal growth factor receptor (EGFR) and nuclear factor \u03baB (NF-\u03baB) by using a molecular docking approach. The binding energies for EGFR were in a range of \u221212.12 (\u00b10.21) to \u22127.34 (\u00b10.07) kcal/mol and those for NF-\u03baB ranged from \u221212.97 (\u00b10.47) to \u22126.24 (\u00b10.06) kcal/mol, indicating similar binding affinities of the curcumin compounds for both target proteins. The predicted receptor-ligand binding constants for EGFR and curcumin derivatives were in a range of 0.00013 (\u00b10.00006) to 3.45 (\u00b10.10) \u00b5M and for NF-\u03baB in a range of 0.0004 (\u00b10.0003) to 10.05 (\u00b14.03) \u00b5M, indicating that the receptor-ligand binding was more stable for EGFR than for NF-\u03baB. Twenty out of 50 curcumin compounds showed binding energies to NF-\u03baB smaller than \u221210 kcal/mol, while curcumin as a lead compound revealed free binding energies of >\u221210 kcal/mol. Comparable data were obtained for EGFR: 15 out of 50 curcumin compounds were bound to EGFR with free binding energies of <\u221210 kcal/mol, while the binding affinity of curcumin itself was >\u221210 kcal/mol. This indicates that the derivatization of curcumin may indeed be a promising strategy to improve targe specificity and to obtain more effective anticancer drug candidates. The in silico results have been exemplarily validated using microscale thermophoresis. The bioactivity has been further investigated by using resazurin cell viability assay, lactate dehydrogenase assay, flow cytometric measurement of reactive oxygen species, and annexin V/propidium iodide assay. In conclusion, molecular docking represents a valuable approach to facilitate and speed up the identification of novel targeted curcumin-based drugs to treat cancer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Saeed", "ForeName": "Mohamed E M", "Initials": "MEM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Hamidiye Faculty of Pharmacy, University of Health Sciences, \u00dcsk\u00fcdar, Istanbul 34668, Turkey."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul 34093, Turkey."}], "LastName": "Y\u00fccer", "ForeName": "R\u00fcmeysa", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}, {"Identifier": [], "Affiliation": "Faculty of Medical Laboratory Sciences, Al-Neelain University, Khartoum 11121, Sudan."}], "LastName": "Dawood", "ForeName": "Mona", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}, {"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Drif", "ForeName": "Assia", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Ooko", "ForeName": "Edna", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Kadioglu", "ForeName": "Onat", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Seo", "ForeName": "Ean-Jeong", "Initials": "EJ"}, {"Identifier": ["0000-0002-9903-9540"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Copenhagen, Universitetsparken 5, 2100 Copenhagen, Denmark."}], "LastName": "Kamounah", "ForeName": "Fadhil S", "Initials": "FS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of the Western Cape, P/B X17, Bellville, Cape Town 7535, South Africa."}], "LastName": "Titinchi", "ForeName": "Salam J", "Initials": "SJ"}, {"Identifier": ["0000-0002-3592-7354"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Biology, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany."}], "LastName": "Bachmeier", "ForeName": "Beatrice", "Initials": "B"}, {"Identifier": ["0000-0002-2637-1681"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "I-kappa B Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "EGFR protein, human"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "ErbB Receptors"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "ErbB Receptors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "I-kappa B Proteins"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}], "CoiStatement": "The authors declare that there is no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Siegel R.L., Miller K.D., Jemal A. Cancer statistics 2018. CA Cancer J. Clin. 2018;68:7\u201330. doi: 10.3322/caac.21442.", "ArticleIdList": ["10.3322/caac.21442", "29313949"]}, {"Citation": "Toyoda Y., Tabuchi T., Nakayama T., Hojo S., Yoshioka S., Maeura Y. Past trends and future estimation of annual breast cancer incidence in Osaka, Japan. Asian Pac. J. Cancer Prev. 2016;17:52.", "ArticleIdList": ["27356700"]}, {"Citation": "Mattiuzzi C., Lippi G. Current cancer epidemiology. J. Epidemiol. Glob. Health. 2019;9:217\u2013222. doi: 10.2991/jegh.k.191008.001.", "ArticleIdList": ["10.2991/jegh.k.191008.001", "PMC7310786", "31854162"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007;70:461\u2013477. doi: 10.1021/np068054v.", "ArticleIdList": ["10.1021/np068054v", "17309302"]}, {"Citation": "Kuete V., Efferth T. African flora has the potential to fight multidrug resistance of cancer. BioMed Res. Int. 2015;2015:914813. doi: 10.1155/2015/914813.", "ArticleIdList": ["10.1155/2015/914813", "PMC4413252", "25961047"]}, {"Citation": "Efferth T., Saeed M.E.M., Kadioglu O., Seo E.J., Shirooie S., Mbaveng A.T., Nabavi S.M., Kuete V. Collateral sensitivity of natural products in drug-resistant cancer cells. Biotechnol. Adv. 2020;38:107342. doi: 10.1016/j.biotechadv.2019.01.009.", "ArticleIdList": ["10.1016/j.biotechadv.2019.01.009", "30708024"]}, {"Citation": "Efferth T., Kadioglu O., Saeed M.E.M., Seo E.-J., Mbaveng A.T., Kuete V. Medicinal plants and phytochemicals against multidrug-resistant tumor cells expressing ABCB1, ABCG2, or ABCB5: A synopsis of 2 decades. Phytochem. Rev. 2021;20:7\u201353. doi: 10.1007/s11101-020-09703-7.", "ArticleIdList": ["10.1007/s11101-020-09703-7"]}, {"Citation": "Sertel S., Plinkert P.K., Efferth T. Natural products derived from traditional Chinese medicine as novel inhibitors of the epidermal growth factor receptor. Comb. Chem. High Throughput Screen. 2010;13:849\u2013854. doi: 10.2174/138620710793360266.", "ArticleIdList": ["10.2174/138620710793360266", "20883187"]}, {"Citation": "Zhao Q., Kretschmer N., Bauer R., Efferth T. Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib. Int. J. Cancer. 2015;137:1446\u20131456. doi: 10.1002/ijc.29483.", "ArticleIdList": ["10.1002/ijc.29483", "25688715"]}, {"Citation": "Saeed M.E.M., Rahama M., Kuete V., Dawood M., Elbadawi M., Sugimoto Y., Efferth T. Collateral sensitivity of drug-resistant ABCB5- and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression. Phytomedicine. 2019;59:152890. doi: 10.1016/j.phymed.2019.152890.", "ArticleIdList": ["10.1016/j.phymed.2019.152890", "30921566"]}, {"Citation": "Lee H.Y.J., Meng M., Liu Y., Su T., Kwan H.Y. Medicinal herbs and bioactive compounds overcome the drug resistance to epidermal growth factor receptor inhibitors in non-small cell lung cancer. Oncol. Lett. 2021;22:646. doi: 10.3892/ol.2021.12907.", "ArticleIdList": ["10.3892/ol.2021.12907", "PMC8299012", "34386068"]}, {"Citation": "Hamdoun S., Efferth T. Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-\u03baB activity. Oncotarget. 2017;8:35103\u201335115. doi: 10.18632/oncotarget.16626.", "ArticleIdList": ["10.18632/oncotarget.16626", "PMC5471038", "28402272"]}, {"Citation": "Chen H., Liu R.H. Potential mechanisms of action of dietary phytochemicals for cancer prevention by targeting cellular signaling transduction pathways. J. Agric. Food. Chem. 2018;66:3260\u20133276. doi: 10.1021/acs.jafc.7b04975.", "ArticleIdList": ["10.1021/acs.jafc.7b04975", "29498272"]}, {"Citation": "Dawood M., Ooko E., Efferth T. Collateral sensitivity of parthenolide via NF-\u03baB and HIF-\u03b1 inhibition and epigenetic changes in drug-resistant cancer cell lines. Front. Pharmacol. 2019;10:542. doi: 10.3389/fphar.2019.00542.", "ArticleIdList": ["10.3389/fphar.2019.00542", "PMC6536578", "31164821"]}, {"Citation": "Menon V.P., Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 2007;595:105\u2013125.", "ArticleIdList": ["17569207"]}, {"Citation": "Moghadamtousi S.Z., Kadir H.A., Hassandarvish P., Tajik H., Abubakar S., Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Res. Int. 2014;2014:186864.", "ArticleIdList": ["PMC4022204", "24877064"]}, {"Citation": "Ooko E., Alsalim T., Saeed B., Saeed M.E., Kadioglu O., Abbo H.S., Titinchi S.J., Efferth T. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines. Tox. Appl. Pharmacol. 2016;305:216\u2013233. doi: 10.1016/j.taap.2016.06.002.", "ArticleIdList": ["10.1016/j.taap.2016.06.002", "27318188"]}, {"Citation": "Liu L., Fu Y., Zheng Y., Ma M., Wang C. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis. Phytomedicine. 2020;78:153312. doi: 10.1016/j.phymed.2020.153312.", "ArticleIdList": ["10.1016/j.phymed.2020.153312", "32866906"]}, {"Citation": "Heshmati J., Moini A., Sepidarkish M., Morvaridzadeh M., Salehi M., Palmowski A., Mojtahedi M.F., Shidfar F. Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. Phytomedicine. 2021;80:153395. doi: 10.1016/j.phymed.2020.153395.", "ArticleIdList": ["10.1016/j.phymed.2020.153395", "33137599"]}, {"Citation": "Seo E.J., Efferth T., Panossian A. Curcumin downregulates expression of opioid-related nociceptin receptor gene (OPRL1) in isolated neuroglia cells. Phytomedicine. 2018;50:285\u2013299. doi: 10.1016/j.phymed.2018.09.202.", "ArticleIdList": ["10.1016/j.phymed.2018.09.202", "30466988"]}, {"Citation": "Hsiao A.F., Lien Y.C., Tzeng I.S., Liu C.T., Chou S.H., Horng Y.S. The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis. Complement. Ther. Med. 2021;63:102775. doi: 10.1016/j.ctim.2021.102775.", "ArticleIdList": ["10.1016/j.ctim.2021.102775", "34537344"]}, {"Citation": "Saghatelyan T., Tananyan A., Janoyan N., Tadevosyan A., Petrosyan H., Hovhannisyan A., Hayrapetyan L., Arustamyan M., Arnhold J., Rotmann A.R., et al. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. 2020;70:153218. doi: 10.1016/j.phymed.2020.153218.", "ArticleIdList": ["10.1016/j.phymed.2020.153218", "32335356"]}, {"Citation": "Zhang T., He Q., Liu Y., Chen Z., Hu H. Efficacy and safety of curcumin supplement on improvement of insulin resistance in people with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Evid.-Based Complement. Altern. Med. 2021;2021:4471944. doi: 10.1155/2021/4471944.", "ArticleIdList": ["10.1155/2021/4471944", "PMC8410384", "34484389"]}, {"Citation": "Sertel S., Eichhorn T., Bauer J., Hock K., Plinkert P.K., Efferth T. Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives. J. Nutr. Biochem. 2012;23:875\u2013884. doi: 10.1016/j.jnutbio.2011.04.012.", "ArticleIdList": ["10.1016/j.jnutbio.2011.04.012", "21865023"]}, {"Citation": "Ye M.X., Li Y., Yin H., Zhang J. Curcumin: Updated molecular mechanisms and intervention targets in human lung cancer. Int. J. Mol. Sci. 2012;13:3959\u20133978. doi: 10.3390/ijms13033959.", "ArticleIdList": ["10.3390/ijms13033959", "PMC3317752", "22489192"]}, {"Citation": "Kong Y., Ma W., Liu X., Zu Y., Fu Y., Wu N., Liang L., Yao L., Efferth T. Cytotoxic activity of curcumin towards CCRF-CEM leukemia cells and its effect on DNA damage. Molecules. 2009;14:5328\u20135338. doi: 10.3390/molecules14125328.", "ArticleIdList": ["10.3390/molecules14125328", "PMC6255027", "20032896"]}, {"Citation": "Tong R., Wu X., Liu Y., Liu Y., Zhou J., Jiang X., Zhang L., He X., Ma L. Curcumin-induced DNA demethylation in human gastric cancer cells is mediated by the DNA-damage response pathway. Oxid. Med. Cell. Longev. 2020;2020:2543504. doi: 10.1155/2020/2543504.", "ArticleIdList": ["10.1155/2020/2543504", "PMC7317311", "32617134"]}, {"Citation": "Bachmeier B., Nerlich A.G., Iancu C.M., Cilli M., Schleicher E., Ven\u00e9 R., Dell\u2019Eva R., Jochum M., Albini A., Pfeffer U. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol. Biochem. 2007;19:137\u2013152. doi: 10.1159/000099202.", "ArticleIdList": ["10.1159/000099202", "17310108"]}, {"Citation": "Killian P.H., Kronski E., Michalik K.M., Barbieri O., Astigiano S., Sommerhoff C.P., Pfeffer U., Nerlich A.G., Bachmeier B.E. Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis. 2012;33:2507\u20132519. doi: 10.1093/carcin/bgs312.", "ArticleIdList": ["10.1093/carcin/bgs312", "23042094"]}, {"Citation": "Kronski E., Fiori M.E., Barbieri O., Astigiano S., Mirisola V., Killian P.H., Bruno A., Pagani A., Rovera F., Pfeffer U., et al. miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL-1 and -2. Mol. Oncol. 2014;8:581\u2013595. doi: 10.1016/j.molonc.2014.01.005.", "ArticleIdList": ["10.1016/j.molonc.2014.01.005", "PMC5528633", "24484937"]}, {"Citation": "Ruiz de Porras V., Bystrup S., Mart\u00ednez-Card\u00fas A., Pluvinet R., Sumoy L., Howells L., James M.I., Iwuji C., Manzano J.L., Layos L., et al. Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-\u03baB signalling pathway. Sci. Rep. 2016;6:24675. doi: 10.1038/srep24675.", "ArticleIdList": ["10.1038/srep24675", "PMC4835769", "27091625"]}, {"Citation": "Norooznezhad F., Rodriguez-Merchan E.C., Asadi S., Norooznezhad A.H. Curcumin: Hopeful treatment of hemophilic arthropathy via inhibition of inflammation and angiogenesis. Expert Rev. Hematol. 2020;13:5\u201311. doi: 10.1080/17474086.2020.1685867.", "ArticleIdList": ["10.1080/17474086.2020.1685867", "31657968"]}, {"Citation": "Bhandarkar S.S., Arbiser J.L. Curcumin as an inhibitor of angiogenesis. Adv. Exp. Med. Biol. 2007;595:185\u2013195.", "ArticleIdList": ["17569211"]}, {"Citation": "Shafiee M., Mohamadzade E., Shahid Sales S., Khakpouri S., Maftouh M., Parizadeh S.A., Hasanian S.M., Avan A. Current status and perspectives regarding the therapeutic potential of targeting EGFR pathway by curcumin in lung cancer. Curr. Pharm. Des. 2017;23:2002\u20132008. doi: 10.2174/1381612823666170123143648.", "ArticleIdList": ["10.2174/1381612823666170123143648", "28117012"]}, {"Citation": "Wan Mohd Tajuddin W.N.B., Lajis N.H., Abas F., Othman I., Naidu R. Mechanistic understanding of curcumin\u2019s therapeutic effects in lung cancer. Nutrients. 2019;11:2989. doi: 10.3390/nu11122989.", "ArticleIdList": ["10.3390/nu11122989", "PMC6950067", "31817718"]}, {"Citation": "Pabla B., Bissonnette M., Konda V.J. Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention. World J. Clin. Oncol. 2015;6:133\u2013141. doi: 10.5306/wjco.v6.i5.133.", "ArticleIdList": ["10.5306/wjco.v6.i5.133", "PMC4600187", "26468449"]}, {"Citation": "Ruiz de Porras V., Layos L., Mart\u00ednez-Balibrea E. Curcumin: A therapeutic strategy for colorectal cancer? Semin. Cancer Biol. 2021;73:321\u2013330. doi: 10.1016/j.semcancer.2020.09.004.", "ArticleIdList": ["10.1016/j.semcancer.2020.09.004", "32942023"]}, {"Citation": "Thomas R.K., Sos M.L., Zander T., Mani O., Popov A., Berenbrinker D., Smola-Hess S., Schultze J.L., Wolf J. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. Clin. Cancer Res. 2005;11:8186\u20138194. doi: 10.1158/1078-0432.CCR-05-0224.", "ArticleIdList": ["10.1158/1078-0432.CCR-05-0224", "16299251"]}, {"Citation": "Zambre A.P., Kulkarni V.M., Padhye S., Sandur S.K., Aggarwal B.B. Novel curcumin analogs targeting TNF-induced NF-kappaB activation and proliferation in human leukemic KBM-5 cells. Bioorg. Med. Chem. 2006;14:7196\u20137204. doi: 10.1016/j.bmc.2006.06.056.", "ArticleIdList": ["10.1016/j.bmc.2006.06.056", "16843665"]}, {"Citation": "Mackenzie G.G., Queisser N., Wolfson M.L., Fraga C.G., Adamo A.M., Oteiza P.I. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin\u2019s lymphoma cells. Int. J. Cancer. 2008;123:56\u201365. doi: 10.1002/ijc.23477.", "ArticleIdList": ["10.1002/ijc.23477", "18386790"]}, {"Citation": "Shehzad A., Lee J., Lee Y.S. Curcumin in various cancers. Biofactors. 2013;39:56\u201368. doi: 10.1002/biof.1068.", "ArticleIdList": ["10.1002/biof.1068", "23303705"]}, {"Citation": "Zhu G., Shen Q., Jiang H., Ji O., Zhu L., Zhang L. Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP signalling. Pharm. Biol. 2020;58:25\u201334. doi: 10.1080/13880209.2019.1701042.", "ArticleIdList": ["10.1080/13880209.2019.1701042", "PMC6968541", "31854220"]}, {"Citation": "Song X., Zhang M., Dai E., Luo Y. Molecular targets of curcumin in breast cancer (Review) Mol. Med. Rep. 2019;19:23\u201329. doi: 10.3892/mmr.2018.9665.", "ArticleIdList": ["10.3892/mmr.2018.9665", "30483727"]}, {"Citation": "Akbari S., Kariznavi E., Jannati M., Elyasi S., Tayarani-Najaran Z. Curcumin as a preventive or therapeutic measure for chemotherapy and radiotherapy induced adverse reaction: A comprehensive review. Food Chem. Toxicol. 2020;145:111699. doi: 10.1016/j.fct.2020.111699.", "ArticleIdList": ["10.1016/j.fct.2020.111699", "32858134"]}, {"Citation": "Ashrafizadeh M., Zarrabi A., Hashemi F., Moghadam E.R., Hashemi F., Entezari M., Hushmandi K., Mohammadinejad R., Najafi M. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sci. 2020;256:117984. doi: 10.1016/j.lfs.2020.117984.", "ArticleIdList": ["10.1016/j.lfs.2020.117984", "32593707"]}, {"Citation": "Liu W., Zhai Y., Heng X., Che F.Y., Chen W., Sun D., Zhai G. Oral bioavailability of curcumin: Problems and advancements. J. Drug Target. 2016;24:694\u2013702. doi: 10.3109/1061186X.2016.1157883.", "ArticleIdList": ["10.3109/1061186X.2016.1157883", "26942997"]}, {"Citation": "Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007;4:807\u2013818. doi: 10.1021/mp700113r.", "ArticleIdList": ["10.1021/mp700113r", "17999464"]}, {"Citation": "Vyas A., Dandawate P., Padhye S., Ahmad A., Sarkar F. Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Curr. Pharm. Des. 2013;19:2047\u20132069.", "ArticleIdList": ["PMC3788358", "23116312"]}, {"Citation": "Ooko E., Kadioglu O., Greten H.J., Efferth T. Pharmacogenomic characterization and isobologram analysis of the combination of ascorbic acid and curcumin-two main metabolites of Curcuma longa-in cancer cells. Front. Pharmacol. 2017;8:38. doi: 10.3389/fphar.2017.00038.", "ArticleIdList": ["10.3389/fphar.2017.00038", "PMC5288649", "28210221"]}, {"Citation": "Karimpour M., Feizi M.A.H., Mahdavi M., Krammer B., Verwanger T., Najafi F., Babaei E. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines. Phytomedicine. 2019;57:183\u2013190. doi: 10.1016/j.phymed.2018.11.017.", "ArticleIdList": ["10.1016/j.phymed.2018.11.017", "30776589"]}, {"Citation": "Moballegh Nasery M., Abadi B., Poormoghadam D., Zarrabi A., Keyhanvar P., Khanbabaei H., Ashrafizadeh M., Mohammadinejad R., Tavakol S., Sethi G. Curcumin delivery mediated by bio-based nanoparticles: A review. Molecules. 2020;25:689. doi: 10.3390/molecules25030689.", "ArticleIdList": ["10.3390/molecules25030689", "PMC7037405", "32041140"]}, {"Citation": "Lin J.K. Molecular targets of curcumin. Adv. Exp. Med. Biol. 2007;595:227\u2013243.", "ArticleIdList": ["17569214"]}, {"Citation": "Sigismund S., Avanzato D., Lanzetti L. Emerging functions of the EGFR in cancer. Mol. Oncol. 2018;12:3\u201320. doi: 10.1002/1878-0261.12155.", "ArticleIdList": ["10.1002/1878-0261.12155", "PMC5748484", "29124875"]}, {"Citation": "Yan G.E., Efferth T. Broad-spectrum cross-resistance to anticancer drugs mediated by epidermal growth factor receptor. Anticancer Res. 2019;39:3585\u20133593. doi: 10.21873/anticanres.13505.", "ArticleIdList": ["10.21873/anticanres.13505", "31262883"]}, {"Citation": "Singh D., Attri B.K., Gill R.K., Bariwal J. Review on EGFR inhibitors: Critical updates. Mini Rev. Med. Chem. 2016;16:1134\u20131166. doi: 10.2174/1389557516666160321114917.", "ArticleIdList": ["10.2174/1389557516666160321114917", "26996617"]}, {"Citation": "Yan G., Saeed M.E.M., Foersch S., Schneider J., Roth W., Efferth T. Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome. Oncotarget. 2019;10:1918\u20131931. doi: 10.18632/oncotarget.26727.", "ArticleIdList": ["10.18632/oncotarget.26727", "PMC6443015", "30956774"]}, {"Citation": "Kadioglu O., Saeed M.E.M., Mahmoud N., Azawi S., Mrasek K., Liehr T., Efferth T. Identification of novel drug resistance mechanisms by genomic and transcriptomic profiling of glioblastoma cells with mutation-activated EGFR. Life Sci. 2021;284:119601. doi: 10.1016/j.lfs.2021.119601.", "ArticleIdList": ["10.1016/j.lfs.2021.119601", "33991550"]}, {"Citation": "Efferth T. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules. Curr. Med. Chem. 2012;19:5735\u20135744. doi: 10.2174/092986712803988884.", "ArticleIdList": ["10.2174/092986712803988884", "23033949"]}, {"Citation": "Kadioglu O., Cao J., Saeed M.E., Greten H.J., Efferth T. Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals. Target. Oncol. 2015;10:337\u2013353. doi: 10.1007/s11523-014-0339-4.", "ArticleIdList": ["10.1007/s11523-014-0339-4", "25410594"]}, {"Citation": "Taniguchi K., Karin M. NF-\u03baB, inflammation, immunity and cancer: Coming of age. Nat. Rev. Immunol. 2018;18:309\u2013324. doi: 10.1038/nri.2017.142.", "ArticleIdList": ["10.1038/nri.2017.142", "29379212"]}, {"Citation": "Hoesel B., Schmid J.A. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol. Cancer. 2013;12:86. doi: 10.1186/1476-4598-12-86.", "ArticleIdList": ["10.1186/1476-4598-12-86", "PMC3750319", "23915189"]}, {"Citation": "Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431\u2013436. doi: 10.1038/nature04870.", "ArticleIdList": ["10.1038/nature04870", "16724054"]}, {"Citation": "Gilmore T.D., Herscovitch M. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene. 2006;25:6887\u20136899. doi: 10.1038/sj.onc.1209982.", "ArticleIdList": ["10.1038/sj.onc.1209982", "17072334"]}, {"Citation": "Gaptulbarova K.A., Tsyganov M.M., Pevzner A.M., Ibragimova M.K., Litviakov N.V. NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer. Exp. Oncol. 2020;42:263\u2013269.", "ArticleIdList": ["33355866"]}, {"Citation": "R\u00edos J.L., Recio M.C., Escandell J.M., And\u00fajar I. Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer. Curr. Pharm. Des. 2009;15:1212\u20131237. doi: 10.2174/138161209787846874.", "ArticleIdList": ["10.2174/138161209787846874", "19355962"]}, {"Citation": "Luqman S., Pezzuto J.M. NFkappaB: A promising target for natural products in cancer chemoprevention. Phytother. Res. 2010;24:949\u2013963. doi: 10.1002/ptr.3171.", "ArticleIdList": ["10.1002/ptr.3171", "20577970"]}, {"Citation": "Soukhtanloo M., Mohtashami E., Maghrouni A., Mollazadeh H., Mousavi S.H., Roshan M.K., Tabatabaeizadeh S.A., Hosseini A., Vahedi M.M., Jalili-Nik M., et al. Natural products as promising targets in glioblastoma multiforme: A focus on NF-\u03baB signaling pathway. Pharmacol. Rep. 2020;72:285\u2013295. doi: 10.1007/s43440-020-00081-7.", "ArticleIdList": ["10.1007/s43440-020-00081-7", "32152926"]}, {"Citation": "Shostak K., Chariot A. EGFR and NF-\u03baB: Partners in cancer. Trends Mol. Med. 2015;21:385\u2013393. doi: 10.1016/j.molmed.2015.04.001.", "ArticleIdList": ["10.1016/j.molmed.2015.04.001", "25979753"]}, {"Citation": "Normanno N., De Luca A., Bianco C., Strizzi L., Mancino M., Maiello M.R., Carotenuto A., De Feo G., Caponigro F., Salomon D.S. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366:2\u201316. doi: 10.1016/j.gene.2005.10.018.", "ArticleIdList": ["10.1016/j.gene.2005.10.018", "16377102"]}, {"Citation": "Starok M., Preira P., Vayssade M., Haupt K., Salome L., Rossi C. EGFR Inhibition by curcumin in cancer cells: A dual mode of action. Biomacromolecules. 2015;16:1634\u20131642. doi: 10.1021/acs.biomac.5b00229.", "ArticleIdList": ["10.1021/acs.biomac.5b00229", "25893361"]}, {"Citation": "Wada K., Lee J.Y., Hung H.Y., Shi Q., Lin L., Zhao Y., Goto M., Yang P.C., Kuo S.C., Chen H.W., et al. Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects. Bioorg. Med. Chem. 2015;23:1507\u20131514. doi: 10.1016/j.bmc.2015.02.003.", "ArticleIdList": ["10.1016/j.bmc.2015.02.003", "PMC4782611", "25753330"]}, {"Citation": "Momtazi A.A., Sahebkar A. Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Curr. Pharm. Des. 2016;22:4386\u20134397. doi: 10.2174/1381612822666160527113501.", "ArticleIdList": ["10.2174/1381612822666160527113501", "27229723"]}, {"Citation": "Hackler L., Jr., Ozsvari B., Gyuris M., Sipos P., Fabian G., Molnar E., Marton A., Farago N., Mihaly J., Nagy L.I., et al. The curcumin analog C-150, influencing NF-kappaB, UPR and Akt/Notch pathways has potent anticancer activity in vitro and in vivo. PLoS ONE. 2016;11:e0149832. doi: 10.1371/journal.pone.0149832.", "ArticleIdList": ["10.1371/journal.pone.0149832", "PMC4778904", "26943907"]}, {"Citation": "Carneiro B.A., El-Deiry W.S. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 2020;17:395\u2013417. doi: 10.1038/s41571-020-0341-y.", "ArticleIdList": ["10.1038/s41571-020-0341-y", "PMC8211386", "32203277"]}, {"Citation": "Wong R.S. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res. 2011;30:87. doi: 10.1186/1756-9966-30-87.", "ArticleIdList": ["10.1186/1756-9966-30-87", "PMC3197541", "21943236"]}, {"Citation": "Reed J.C. Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol. Oncol. Clin. N. Am. 1995;9:451\u2013473. doi: 10.1016/S0889-8588(18)30104-7.", "ArticleIdList": ["10.1016/S0889-8588(18)30104-7", "7642473"]}, {"Citation": "Gottesman M.M. Mechanisms of cancer drug resistance. Annu. Rev. Med. 2002;53:615\u2013627. doi: 10.1146/annurev.med.53.082901.103929.", "ArticleIdList": ["10.1146/annurev.med.53.082901.103929", "11818492"]}, {"Citation": "Kadioglu O., Saeed M.E., Valoti M., Frosini M., Sgaragli G., Efferth T. Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses. Biochem. Pharmacol. 2016;104:42\u201351. doi: 10.1016/j.bcp.2016.01.014.", "ArticleIdList": ["10.1016/j.bcp.2016.01.014", "26807479"]}, {"Citation": "Abdelfatah S., B\u00f6ckers M., Asensio M., Kadioglu O., Klinger A., Fleischer E., Efferth T. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells. Phytomedicine. 2021;86:153196. doi: 10.1016/j.phymed.2020.153196.", "ArticleIdList": ["10.1016/j.phymed.2020.153196", "32229058"]}, {"Citation": "Lu X., Yan G., Dawood M., Klauck S.M., Sugimoto Y., Klinger A., Fleischer E., Shan L., Efferth T. A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells. Biochem. Pharmacol. 2021;194:114677. doi: 10.1016/j.bcp.2021.114677.", "ArticleIdList": ["10.1016/j.bcp.2021.114677", "34265280"]}, {"Citation": "Na\u00df J., Abdelfatah S., Efferth T. The triterpenoid ursolic acid ameliorates stress in Caenorhabditis elegans by affecting the depression-associated genes skn-1 and prdx2. Phytomedicine. 2021;88:153598. doi: 10.1016/j.phymed.2021.153598.", "ArticleIdList": ["10.1016/j.phymed.2021.153598", "34111615"]}, {"Citation": "Kumar S., Ahuja V., Sankar M.J., Kumar A., Moss A.C. Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database Syst. Rev. 2012;10:CD008424.", "ArticleIdList": ["PMC4001731", "23076948"]}, {"Citation": "Bukhari S.N., Franzblau S.G., Jantan I., Jasamai M. Current prospects of synthetic curcumin analogs and chalcone derivatives against Mycobacterium tuberculosis. Med. Chem. 2013;9:897\u2013903. doi: 10.2174/1573406411309070002.", "ArticleIdList": ["10.2174/1573406411309070002", "23305394"]}, {"Citation": "Monroy A., Lithgow G.J., Alavez S. Curcumin and neurodegenerative diseases. BioFactors. 2013;39:122\u2013132. doi: 10.1002/biof.1063.", "ArticleIdList": ["10.1002/biof.1063", "PMC3578106", "23303664"]}, {"Citation": "Cicero A.F., Colletti A. Role of phytochemicals in the management of metabolic syndrome. Phytomedicine. 2016;23:1134\u20131144. doi: 10.1016/j.phymed.2015.11.009.", "ArticleIdList": ["10.1016/j.phymed.2015.11.009", "26778479"]}, {"Citation": "Hernandez M., Wicz S., Corral R.S. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E2 pathway induced during Trypanosoma cruzi infection. Phytomedicine. 2016;23:1392\u20131400. doi: 10.1016/j.phymed.2016.06.017.", "ArticleIdList": ["10.1016/j.phymed.2016.06.017", "27765359"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "29"}, {"Year": "2022", "Month": "3", "Day": "28"}, {"Year": "2022", "Month": "3", "Day": "29"}, {"Year": "2022", "Month": "4", "Day": "12", "Hour": "1", "Minute": "13"}, {"Year": "2022", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["35409325", "PMC9000198", "10.3390/ijms23073966", "ijms23073966"]}}], "PubmedBookArticle": []}